Gladstone Institutional Advisory LLC Moderna, Inc. Transaction History

Gladstone Institutional Advisory LLC

$1.9 Billion
Q2 2024

A detailed history of Gladstone Institutional Advisory LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 3,926 shares of MRNA stock, worth $258,134. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,926

Holding current value

$258,134

% of portfolio

0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $397,350 - $654,110	3,926 New	3,926 $466,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $35,478 - $46,592	368 Added 20.35%	2,176 $224,000
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $17,775 - $24,079	-150 Reduced 7.66%	1,808 $219,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $4,341 - $6,304	-32 Reduced 1.61%	1,958 $300,000
Q4 2022 Feb 01, 2023	SELL	$118.38 - $210.04 $42,971 - $76,244	-363 Reduced 15.43%	1,990 $357,000
Q3 2022 Jan 27, 2023	SELL	$118.07 - $194.18 $7,556 - $12,427	-64 Reduced 2.65%	2,353 $278,000
Q3 2022 Oct 20, 2022	SELL	$118.07 - $194.18 $7,556 - $12,427	-64 Reduced 2.65%	2,353 $278,000
Q2 2022 Jan 27, 2023	SELL	$117.13 - $176.59 $335,343 - $505,577	-2,863 Reduced 54.22%	2,417 $345,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $335,343 - $505,577	-2,863 Reduced 54.22%	2,417 $345,000
Q1 2022 Jan 27, 2023	SELL	$126.46 - $235.05 $215,867 - $401,230	-1,707 Reduced 24.43%	5,280 $910,000
Q1 2022 May 04, 2022	SELL	$126.46 - $235.05 $215,867 - $401,230	-1,707 Reduced 24.43%	5,280 $910,000
Q4 2021 Jan 27, 2023	SELL	$225.82 - $368.51 $90,553 - $147,772	-401 Reduced 5.43%	6,987 $1.78 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $90,553 - $147,772	-401 Reduced 5.43%	6,987 $1.78 Million
Q3 2021 Jan 27, 2023	SELL	$221.9 - $484.47 $190,390 - $415,675	-858 Reduced 10.41%	7,388 $2.84 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $190,390 - $415,675	-858 Reduced 10.41%	7,388 $2.84 Million
Q2 2021 Jan 27, 2023	BUY	$129.91 - $234.98 $864,031 - $1.56 Million	6,651 Added 416.99%	8,246 $1.94 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $864,031 - $1.56 Million	6,651 Added 416.99%	8,246 $1.94 Million
Q1 2021 Jan 27, 2023	SELL	$109.18 - $185.98 $540,441 - $920,601	-4,950 Reduced 75.63%	1,595 $209,000
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $540,441 - $920,601	-4,950 Reduced 75.63%	1,595 $209,000
Q4 2020 Jan 27, 2023	SELL	$65.74 - $169.86 $155,738 - $402,398	-2,369 Reduced 26.58%	6,545 $684,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $155,738 - $402,398	-2,369 Reduced 26.58%	6,545 $684,000
Q3 2020 Jan 27, 2023	BUY	$54.34 - $94.85 $356,524 - $622,310	6,561 Added 278.84%	8,914 $631,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $808,579 - $1.41 Million	-14,880 Reduced 62.54%	8,914 $631,000
Q2 2020 Aug 17, 2020	BUY	$29.67 - $80.0 $438,107 - $1.18 Million	14,766 Added 163.56%	23,794 $1.53 Million
Q1 2020 May 14, 2020	BUY	$17.78 - $31.58 $160,517 - $285,104	9,028 New	9,028 $270,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Account

Gladstone Institutional Advisory LLC Moderna, Inc. Transaction History